WO1993016981A1 - Synthesis of ioversol using a minimal excess of acetoxyacetylchloride - Google Patents

Synthesis of ioversol using a minimal excess of acetoxyacetylchloride Download PDF

Info

Publication number
WO1993016981A1
WO1993016981A1 PCT/US1993/002033 US9302033W WO9316981A1 WO 1993016981 A1 WO1993016981 A1 WO 1993016981A1 US 9302033 W US9302033 W US 9302033W WO 9316981 A1 WO9316981 A1 WO 9316981A1
Authority
WO
WIPO (PCT)
Prior art keywords
triiodoisophthalamide
bis
diacetoxypropyl
reaction mixture
organic solvent
Prior art date
Application number
PCT/US1993/002033
Other languages
French (fr)
Inventor
William Z. Mc Carthy
Mills Thomas Kneller
Youlin Lin
Rebecca Abernathy Wallace
David Hill White
Original Assignee
Mallinckrodt Medical, Inc.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Mallinckrodt Medical, Inc. filed Critical Mallinckrodt Medical, Inc.
Priority to JP5515135A priority Critical patent/JPH07504419A/en
Priority to EP93907271A priority patent/EP0628024A4/en
Publication of WO1993016981A1 publication Critical patent/WO1993016981A1/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C237/00—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups
    • C07C237/28—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups having the carbon atom of at least one of the carboxamide groups bound to a carbon atom of a non-condensed six-membered aromatic ring of the carbon skeleton
    • C07C237/46—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups having the carbon atom of at least one of the carboxamide groups bound to a carbon atom of a non-condensed six-membered aromatic ring of the carbon skeleton having carbon atoms of carboxamide groups, amino groups and at least three atoms of bromine or iodine, bound to carbon atoms of the same non-condensed six-membered aromatic ring
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C231/00—Preparation of carboxylic acid amides
    • C07C231/02—Preparation of carboxylic acid amides from carboxylic acids or from esters, anhydrides, or halides thereof by reaction with ammonia or amines

Definitions

  • the present invention relates to the use of a minimal excess of acetoxyacetylchloride as a reagent in the synthesis of ioversol.
  • Ioversol is disclosed as a useful nonionic x-ray contrast agent in U.S. Patent No. 4,396,598.
  • 5-acetoxyacetamido-N,N'-bis(2,3-diacetoxypropyl)-2,4,6-triiodoisophthalamide having the following structure:
  • 5-acetoxyacetamido-N,N'-bis(2,3-diacetoxypropyl)-2,4,6-triiodoisophthalamide may be produced by adding acetoxyacetylchloride (AAC) to a N,N-dimethylacetamide and 1,1,2-trichloroethane solution of a compound of the following structure: and stirring until the reaction is complete. The reaction mixture is then diluted with 1,1,2-trichloroethane and extracted with aqueous sodium bicarbonate solutions and aqueous sodium chloride solutions.
  • AAC acetoxyacetylchloride
  • the dilution procedure using 1,1,2-trichloroethane may alternatively be carried out using an organic solvent such as, but not limited to, carbon tetrachloride, dichloromethane, chloroform, 1,2-dichloroethane, 1,1,2-trichloroethylene, 1,1,2-trichloroethane, 1,1,1-trichloroethane and tetrachloroethylene, but most preferably 1,1,2-trichloroethane.
  • an organic solvent such as, but not limited to, carbon tetrachloride, dichloromethane, chloroform, 1,2-dichloroethane, 1,1,2-trichloroethylene, 1,1,2-trichloroethane, 1,1,1-trichloroethane and tetrachloroethylene, but most preferably 1,1,2-trichloroethane.
  • the present invention is a method of producing ioversol using only approximately 7 to 36%, but preferably a 12% excess, of acetoxyacetylchloride (AAC) as opposed to a 100% excess as taught by prior art.
  • AAC acetoxyacetylchloride
  • the procedure begins with a solvent solution of 5-amino-N,N'-bis(2,3-diacetoxypropyl)-2,4,6-triiodoisophthalamide(1).
  • Compound 1 may be prepared for use in this reaction by distilling off some of the solvent to remove and/or reduce impurities, or alternatively, the solvent solution may be used directly without distillation.
  • N,N-dimethylacetamide (DMAC) and acetoxyacetylchloride (AAC), are then added to between 1 to 3 grams, but preferably 1.72 grams, of 5-amino-N,N'-bis(2,3-diacetoxypropyl)-2,4,6-triiodoisophthalamide (1) plus up to 5 milliliters, but preferably 1 milliliter of suitable solvent to form a highly concentrated solution.
  • the concentrated solution is then stirred at a temperature within the range of 40° C to 66° C but preferably at the optimal temperature of 50°C, as opposed to the temperature of 37° C taught by prior art, until the reaction is complete.
  • Hydrochloric acid is produced as a waste product of this reaction.
  • the DMAC present in the solution is mildly basic and thereby reacts with the hydrochloric acid generated to form a DMAC ⁇ HCl complex. After dilution with an organic solvent, the reaction solution is extracted with aqueous sodium bicarbonate solution(s) and aqueous sodium chloride solution(s).
  • the resulting 5-(acetoxyacetamido)-N,N' -bis (2 , 3-diacetoxypropyl) -2 , 4 , 6-triiodoisophthalamide(2) may be used without further purification as an intermediate in the production of N,N'-bis(2,3-dihydroxypropyl)-5-[N-(2-hydroxyethyl)glycolamido]- 2,4,6-triiodoisophthalamide (ioversol) (4) according to the reactions illustrated in Scheme 1 below.
  • the final product, ioversol (4), produced through the use of only a 12% excess of AAC has an equivalent or increased purity, approximately 95%, as compared to that produced through the use of 100% excess AAC as previously believed necessary to reach such levels of purity.
  • AAC Acetoxyacetylchloride
  • DMAC N,N-dimethylacetamide
  • TCE 1,1,2-trichloroethane
  • DMSO Dimethylsulfoxide
  • AAC Acetoxyacetylchloride
  • DMAC N,N-dimethylacetamide
  • TCE 1,1,2-trichloroethane
  • DMSO Dimethylsulfoxide
  • AAC Acetoxyacetylchloride
  • DMAC N,N-dimethylacetamide
  • TCE 1,1,2-trichloroethane
  • DMSO Dimethylsulfoxide
  • AAC Acetoxyacetylchloride
  • this particular method combines two reaction steps into one simplified reaction step, namely the production of 5-amino-N,N'-bis(2,3-diacetoxypropyl)-2,4,6-triiodoisophthalamide(1), in the production of ioversol(4).
  • This step-saving and time-saving method begins by adding N,N-dimethyl-acetamide (DMAC) and acetoxyacetylchloride (AAC) to 5-amino-N,N'-bis(2,3-dihydroxypropyl)-2,4,6-triiodoisophthalamide (5) and stirring until the reaction is complete.
  • DMAC N,N-dimethyl-acetamide
  • AAC acetoxyacetylchloride
  • Elimination of the need for the 100% excess of acetoxyacetylchloride is important to reduce the costs of production and to provide alternative routes of production for N,N'-bis(2,3-dihydroxypropyl)-5-[N-(2-hydroxyethyl)-glycolamido]-2,4,6-triiodoisophthalamide(4). Additionally, the need for acetic anhydride is likewise eliminated through the process illustrated in Scheme 2 which reduces the cost of production even further.
  • 5-acetoxyacetamido-N,N'-bis(2,3-diacetoxypropyl)-2,4,6-triiodoisophthalamide (2) may be prepared according to the present invention by first distilling off some of the solvents from 5-amino-N,N'-bis(2,3-diacetoxypropyl)-2,4,6-triiodoisophthalamide(1) to reduce and/or remove any solvent impurities therefrom. This distillation of solvent(s) from compound 1 is optional.
  • N,N-dimethylacetamide (DMAC) and a 7 to 36%, but preferably a 12%, excess of acetoxyacetychloride is then added to the previously distilled solution and stirred at preferably 50°C until the acylation reaction is complete.
  • the optimal temperature is within the range of 40° C to 66° C, however, 50° C was determined to be most preferable based on the experimental results illustrated in Table 1 below.
  • An organic solvent such as for example toluene, a halocarbon solvent or a chlorocarbon solvent is used for the dilution.
  • suitable solvents for dilution also include, but are not limited to carbon tetrachloride, dichloromethane, chloroform, 1,2-dichloroethane, 1,1,2-trichloroethylene, 1,1,2-dichloroethane, 1,1,1-trichloroethane and tetrachloroethylene, but preferably 1,1,2-trichloroethane.
  • the solvent is extracted with aqueous sodium bicarbonate solution(s) (preferably containing approximately 10-15% sodium bicarbonate) and/or aqueous sodium chloride solutions (preferably containing approximately 10-15% sodium chloride).
  • aqueous sodium bicarbonate solution(s) preferably containing approximately 10-15% sodium bicarbonate
  • aqueous sodium chloride solutions preferably containing approximately 10-15% sodium chloride
  • the resulting 5-acetoxyacetamido-N,N'-bis(2,3-diacetoxypropyl)-2,4,6-triiodoisophthalamide(2) may be used as an intermediate to produce N,N'-bis(2,3-dihydroxypropyl)-5-[N-(2-hydroxyethyl)glycolamido]-2,4,6-triiodoisophthalamide (ioversol) (4) as illustrated in Scheme 1 above.
  • N,N'-bis(2,3-dihydroxypropyl)-5-[N-(2-hydroxyethyl)glycolamido]-2,4,6-triiodoisophthalamide (ioversol) (4) from 5-amino-N,N'-bis(2,3-dihydroxypropyl)-2,4,6-triiodoisophthalamide(5) stirred with acetoxyacetylchloride (AAC), N,N-dimethylacetamide (DMAC) and optionally 4-dimethylaminopyridine (DMAP) likewise may be used as an intermediate to produce ioversol as is illustrated in Scheme 2 above.
  • AAC acetoxyacetylchloride
  • DMAC N,N-dimethylacetamide
  • DMAP 4-dimethylaminopyridine
  • DMAC N,N-dimethyl-acetamide
  • Acetoxyacetylchloride (0.55 g mole, 7.45 g) is added slowly with stirring and the reaction temperature is controlled at 40-66°C. After completing the addition, the reaction solution is allowed to stir at approximately 50°C to complete the reaction, i.e., approximately three hours.
  • TCE 1,1,2-trichloroethane
  • aqueous sodium carbonate solution approximately 0.6 moles, 52 g in a 13% w/v solution is slowly added to the stirred TCE solution at a rate which will maintain the temperature at less than 27°C.
  • reaction mixture containing TCE, DMAC, AAC, 5-amino-N,N-bis(2,3-dihydroxypropyl)-2,4,6-triiodoisophthalamide is transferred to a separatory funnel and the organic layer is separated from the aqueous layer. The organic layer is washed with a 10% w/v sodium chloride solution in a similar manner.
  • the resulting TCE solution of the product is suitable for conversion to N,N-bis(2,3-dihydroxypropyl)-5-[N-(2-hydroxyethyl)glycolamido]-2,4,6-triiodoisophthalamide (ioversol) as shown in Scheme 2 above.

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)

Abstract

The use of a minimal excess of acetoxyacetylchloride as a reagent in the synthesis of N, N'-bis (2,3-dihydroxypropyl)-5-N-(2-hydroxyethyl)glycolamido-2,4,6-triiodoisophthalamide.

Description

SYNTHESIS OF lOVERSOL USING A MINIMAL EXCESS
OF ACETOXYACETYLCHLORIDE
Field of the Invention
The present invention relates to the use of a minimal excess of acetoxyacetylchloride as a reagent in the synthesis of ioversol.
Background of the Invention
Ioversol is disclosed as a useful nonionic x-ray contrast agent in U.S. Patent No. 4,396,598. 5-acetoxyacetamido-N,N'-bis(2,3-diacetoxypropyl)-2,4,6-triiodoisophthalamide having the following structure:
Figure imgf000003_0001
is an intermediate compound in the production of ioversol. The compound of Formula I and its use in the production of ioversol is likewise disclosed in U.S. Patent No. 4,396,598 incorporated herein by reference. 5-acetoxyacetamido-N,N'-bis(2,3-diacetoxypropyl)-2,4,6-triiodoisophthalamide, as disclosed in U.S. Patent No. 4,396,598, may be produced by adding acetoxyacetylchloride (AAC) to a N,N-dimethylacetamide and 1,1,2-trichloroethane solution of a compound of the following structure:
Figure imgf000004_0001
and stirring until the reaction is complete. The reaction mixture is then diluted with 1,1,2-trichloroethane and extracted with aqueous sodium bicarbonate solutions and aqueous sodium chloride solutions.
The dilution procedure using 1,1,2-trichloroethane may alternatively be carried out using an organic solvent such as, but not limited to, carbon tetrachloride, dichloromethane, chloroform, 1,2-dichloroethane, 1,1,2-trichloroethylene, 1,1,2-trichloroethane, 1,1,1-trichloroethane and tetrachloroethylene, but most preferably 1,1,2-trichloroethane.
The procedure for producing 5-acetoxyacetamido-N,N'-bis(2,3-diacetoxypropyl)-2,4,6-triiodoisophthalamide has become well known in the art and heretofore required the use of a 100% excess of acetoxyacetylchloride (AAC) to perform the intermediate synthetic step just described.
An improved procedure that minimizes the need for acetoxyacetylchloride (AAC) in the intermediate synthetic step which produces 5-acetoxyacetamido-N,N'-bis(2,3-diacetoxypropyl)-2,4,6-triiodoisophthalamide is desired as an alternate and more cost efficient method of producing ioversol. It is, therefore, an object of the present invention to meet these needs.
Summary of the Invention
The present invention is a method of producing ioversol using only approximately 7 to 36%, but preferably a 12% excess, of acetoxyacetylchloride (AAC) as opposed to a 100% excess as taught by prior art. The procedure begins with a solvent solution of 5-amino-N,N'-bis(2,3-diacetoxypropyl)-2,4,6-triiodoisophthalamide(1). Compound 1 may be prepared for use in this reaction by distilling off some of the solvent to remove and/or reduce impurities, or alternatively, the solvent solution may be used directly without distillation. N,N-dimethylacetamide (DMAC) and acetoxyacetylchloride (AAC), are then added to between 1 to 3 grams, but preferably 1.72 grams, of 5-amino-N,N'-bis(2,3-diacetoxypropyl)-2,4,6-triiodoisophthalamide (1) plus up to 5 milliliters, but preferably 1 milliliter of suitable solvent to form a highly concentrated solution. The concentrated solution is then stirred at a temperature within the range of 40° C to 66° C but preferably at the optimal temperature of 50°C, as opposed to the temperature of 37° C taught by prior art, until the reaction is complete. Hydrochloric acid is produced as a waste product of this reaction. The DMAC present in the solution is mildly basic and thereby reacts with the hydrochloric acid generated to form a DMAC·HCl complex. After dilution with an organic solvent, the reaction solution is extracted with aqueous sodium bicarbonate solution(s) and aqueous sodium chloride solution(s). The resulting 5-(acetoxyacetamido)-N,N' -bis (2 , 3-diacetoxypropyl) -2 , 4 , 6-triiodoisophthalamide(2) may be used without further purification as an intermediate in the production of N,N'-bis(2,3-dihydroxypropyl)-5-[N-(2-hydroxyethyl)glycolamido]- 2,4,6-triiodoisophthalamide (ioversol) (4) according to the reactions illustrated in Scheme 1 below. The final product, ioversol (4), produced through the use of only a 12% excess of AAC, has an equivalent or increased purity, approximately 95%, as compared to that produced through the use of 100% excess AAC as previously believed necessary to reach such levels of purity.
Figure imgf000007_0001
SCHEME 1
AAC = Acetoxyacetylchloride DMAC = N,N-dimethylacetamide TCE = 1,1,2-trichloroethane DMSO = Dimethylsulfoxide Another method of producing ioversol according to the present invention using a minimal excess, such as 7 to 36% but preferably 12% acetoxyacetylchloride (AAC), uses dried 5-amino-N,N,bis(2,3-dihydroxypropyl)-2,4,6-triiodoisophthalamide(5) which normally serves as a precursor to 5-amino-N,N'bis(2,3-diacetoxypropyl)-2,4,6-triiodoisophthalamide(1) in the ioversol process. Therefore, this particular method combines two reaction steps into one simplified reaction step, namely the production of 5-amino-N,N'-bis(2,3-diacetoxypropyl)-2,4,6-triiodoisophthalamide(1), in the production of ioversol(4). This step-saving and time-saving method begins by adding N,N-dimethyl-acetamide (DMAC) and acetoxyacetylchloride (AAC) to 5-amino-N,N'-bis(2,3-dihydroxypropyl)-2,4,6-triiodoisophthalamide (5) and stirring until the reaction is complete. (4-dimethyl-aminopyridine (DMAP) may also be used as a catalyst and added to compound (5) along with the DMAC and AAC although it is not necessary.) Hydrochloric acid is produced as a waste product of this reaction. After dilution with an organic solvent, the reaction solution is extracted with aqueous sodium bicarbonate solution(s) and aqueous sodium chloride solution(s). The resulting pentaacetate-derivative of 5-acetoxyacetamido-N,N'-bis (2 , 3-diacetoxypropyl) -2 , 4 , 6-triiodoisophthalamide(6) may be used without further purification in the production of N,N'-bis(2,3-dihydroxypropyl)-5-[N-(2-hydroxyethyl)glycolamido]-2,4,6-triiodoisophthalamide (ioversol) (4) according to the reactions illustrated in Scheme 2 below.
Figure imgf000009_0001
SCHEME 2
AAC = Acetoxyacetylchloride DMAC = N,N-dimethylacetamide DMAP = 4-dimethylaminopyridine DMSO = Dimethylsulfoxide Both of the above-described processes, through an increase in the reaction solution concentration and an increase in temperature, have the advantage of eliminating the need for a 100% excess of acetoxyacetylchloride in the intermediate synthetic steps used in the production of N,N'-bis(2, 3-dihydroxypropyl) -5-[N-(2-hydroxyethyl)glycolamido]-2,4,6-triiodoisophthalamide (ioversol). Elimination of the need for the 100% excess of acetoxyacetylchloride is important to reduce the costs of production and to provide alternative routes of production for N,N'-bis(2,3-dihydroxypropyl)-5-[N-(2-hydroxyethyl)-glycolamido]-2,4,6-triiodoisophthalamide(4). Additionally, the need for acetic anhydride is likewise eliminated through the process illustrated in Scheme 2 which reduces the cost of production even further.
Detailed Description of the Invention 5-acetoxyacetamido-N,N'-bis(2,3-diacetoxypropyl)-2,4,6-triiodoisophthalamide (2) may be prepared according to the present invention by first distilling off some of the solvents from 5-amino-N,N'-bis(2,3-diacetoxypropyl)-2,4,6-triiodoisophthalamide(1) to reduce and/or remove any solvent impurities therefrom. This distillation of solvent(s) from compound 1 is optional. N,N-dimethylacetamide (DMAC) and a 7 to 36%, but preferably a 12%, excess of acetoxyacetychloride is then added to the previously distilled solution and stirred at preferably 50°C until the acylation reaction is complete. The optimal temperature is within the range of 40° C to 66° C, however, 50° C was determined to be most preferable based on the experimental results illustrated in Table 1 below.
Controlled Factors CharacteristicRUN * - - - - - - - - * - - - - - - - - * - - - - - - - - * * - - - - - - - - * # AAC TEMP GPML AREA1
1 1.570 40.00 0.670 49.30
2 1.570 40.00 0.670 52.00
3 1.570 60.00 0.670 74.00 4 1.570 41.00 0.400 18.00
5 1.570 40.00 1.000 66.90 6 1.570 40.00 1.000 65.00 7 1.050 50.00 1.000 70.10
8 1.100 50.00 1.000 69.40 9 1.110 51.00 1.250 84.20
10 2.230 51.00 1.250 97.70 11 1.110 62.00 1.520 83.40 12 1.670 62.00 1.520 93.40 13 1.050 40.00 1.670 66.20 14 1.050 50.00 1.670 90.30 15 2.000 40.00 1.280 80.50 16 0.970 54.00 1.940 87.00
17 1.220 50.00 1.190 86.80 18 1.050 50.00 1.620 88.90
TABLE 1 The resulting solution after acylation is highly viscous and is therefore diluted to improve fluidity, and thereby ease workability. An organic solvent such as for example toluene, a halocarbon solvent or a chlorocarbon solvent is used for the dilution. Examples of such suitable solvents for dilution also include, but are not limited to carbon tetrachloride, dichloromethane, chloroform, 1,2-dichloroethane, 1,1,2-trichloroethylene, 1,1,2-dichloroethane, 1,1,1-trichloroethane and tetrachloroethylene, but preferably 1,1,2-trichloroethane.
After dilution, the solvent is extracted with aqueous sodium bicarbonate solution(s) (preferably containing approximately 10-15% sodium bicarbonate) and/or aqueous sodium chloride solutions (preferably containing approximately 10-15% sodium chloride). This usually results in a mixture of 5-acetoxyacetamido-N,N'-bis(2,3-diacetoxypropyl)-2,4,6-triiodoisophthalamide(2) in 1,1,2-trichloroethane at approximately 25 to 30 percent solids. The resulting 5-acetoxyacetamido-N,N'-bis(2,3-diacetoxypropyl)-2,4,6-triiodoisophthalamide(2) may be used as an intermediate to produce N,N'-bis(2,3-dihydroxypropyl)-5-[N-(2-hydroxyethyl)glycolamido]-2,4,6-triiodoisophthalamide (ioversol) (4) as illustrated in Scheme 1 above. The production of N,N'-bis(2,3-dihydroxypropyl)-5-[N-(2-hydroxyethyl)glycolamido]-2,4,6-triiodoisophthalamide (ioversol) (4) from 5-amino-N,N'-bis(2,3-dihydroxypropyl)-2,4,6-triiodoisophthalamide(5) stirred with acetoxyacetylchloride (AAC), N,N-dimethylacetamide (DMAC) and optionally 4-dimethylaminopyridine (DMAP) likewise may be used as an intermediate to produce ioversol as is illustrated in Scheme 2 above. The present invention as described above is further illustrated by the following examples, but is not intended to be limited thereby.
Example 1: The Preparation of 5-acetoxyacetamido-N,N'-bis- (2,3-diacetoxypropyl)-2,4,6-triiodoisophthalamide
A solution of 5-amino-N,N'-bis(2,3-diacetoxypropyl)-2,4,6-triiodoisophthalamide (214.06 g) in 1,1,2-trichloroethane (TCE), i.e., approximately 200 g of 5-amino-N,N'-bis(2,3-diacetoxypropyl-2,4,6-triiodoisophthalamide in 14.06 g or 10 mL TCE, was
prepared. N,N-dimethyl-acetamide (DMAC) 58.5 mL and 48.5 mL TCE were then added to the flask. The flask was heated to 50° C and 35.03 g of AAC was added and the reaction was stirred until the reaction was complete.
The reaction mixture was then diluted with 1,1,2-trichloroethane (236 mL) and extracted with approximately 10% aqueous sodium bicarbonate (987 mL H2O: 98.7 g NaHCO3) and 10% aqueous sodium chloride (415 mL H2O: 41.5 g NaCl). The resulting solution of 5-acetoxyacetamido-N,N'-bis(2,3-diacetoxypropyl)-2,4,6-triiodoisophthalamide (2) requires no further purification.
Example 2:
The Preparation of 5-acetoxyacetamido-N,N-bis[2,3- di(acetoxyacetoxypropyl)]-2,4,6-triiodoisophthalamide N,N-dimethylacetamide (75.2 ml), 4-dimethylaminopyridine (.005 g moles, 0.61 g) and granular 5-amino-N,N-bis(2,3-dihydroxypropyl)-2,4,6-triiodoisophthalamide (0.1 g mole, 70.5 g) are placed into a 500 ml, 3-necked round bottomed flask. The mixture is stirred and heated to approximately 55°C to dissolve the solids. Acetoxyacetylchloride (0.55 g mole, 7.45 g) is added slowly with stirring and the reaction temperature is controlled at 40-66°C. After completing the addition, the reaction solution is allowed to stir at approximately 50°C to complete the reaction, i.e., approximately three hours.
After the reaction is completed, 1,1,2-trichloroethane (TCE) is added (approximately 152 ml) diluting the solution by approximately a factor of 3 and the solution is stirred and cooled to approximately 20°C. Stirring and cooling are continued and aqueous sodium carbonate solution (approximately 0.6 moles, 52 g in a 13% w/v solution is slowly added to the stirred TCE solution at a rate which will maintain the temperature at less than 27°C. After stirring for 30 minutes, the reaction mixture containing TCE, DMAC, AAC, 5-amino-N,N-bis(2,3-dihydroxypropyl)-2,4,6-triiodoisophthalamide is transferred to a separatory funnel and the organic layer is separated from the aqueous layer. The organic layer is washed with a 10% w/v sodium chloride solution in a similar manner. The resulting TCE solution of the product is suitable for conversion to N,N-bis(2,3-dihydroxypropyl)-5-[N-(2-hydroxyethyl)glycolamido]-2,4,6-triiodoisophthalamide (ioversol) as shown in Scheme 2 above.

Claims

The process of the present invention is less expensive, easier to perform and results in the same or fewer impurities. Accordingly, having described our invention, we claim: 1. A process for the production of 5-acetoxyacetamido- N,N'-bis(2,3-diacetoxypropyl)-2,4,6- triiodoisophthalamide from 5-amino-N,N'-bis(2,3- diacetoxypropyl)-2,4,6-triiodoisophthalamide, comprising the steps of:
a. reacting N,N-dimethylacetamide, a reduced excess of acetoxyacetylchloride, 5-amino-N,N'-bis(2,3- diacetoxypropyl)-2,4,6-triiodoisophthalamide and an organic solvent under reaction forming conditions to form a reaction mixture; and b. recovering 5-acetoxyacetamido-N,N'-bis-(2,3- diacetoxypropyl)-2,4,6-triiodoisophthalamide.
2. The process of claim 1 wherein said reaction mixture is diluted with an organic solvent prior to recovering 5-acetoxyacetamido-N,N'-bis-(2,3-diacetoxypropyl)- 2,4,6-triiodoisophthalamide.
3. The process of claim 1 wherein said reaction mixture is diluted with an organic solvent and extracted with an aqueous solution prior to recovering 5- acetoxyacetamido-N,N'-bis-(2,3-diacetoxypropyl)-2,4,6- triiodoisophthalamide.
4. The process of claim 1 wherein said reaction mixture is formed at a temperature within the range of 40° to 66° C.
5. The process of claim 1 wherein said reaction mixture is formed at a temperature of 50° C.
6. The process of claim 1 wherein said excess of acetoxyacetylchloride is approximately 7 to 36%.
7. The process of claim 1 wherein said excess of acetoxyacetylchloride is 12%.
8. The process of claim 1 wherein a highly concentrated solution of said 5-amino-N,N'-bis-(2,3- diacetoxypropyl)-2,4,6-triiodoisophthalamide and said organic solvent is used to form said reaction mixture.
9. The process of claim 1 wherein one to three grams of said 5-amino-N,N'-bis(2,3-diacetoxypropyl)-2,4,6- triiodoisophthalamide plus up to five milliliters of said organic solvent are stirred to form a highly concentrated solution used to form said reaction mixture.
10. The process of claim 1, wherein 1.72 grams of said 5- amino-N,N'-bis(2,3-diacetoxypropyl)-2,4,6- triiodoisophthalamide plus one milliliter of
said organic solvent are stirred to form a highly concentrated solution used to form said reaction mixture.
11. The process of claim 1, wherein said organic solvent may be the same or different selected from a group consisting of carbontetrachloride, dichloromethane, chloroform, toluene, 1,2-dichloroethane, 1,1,2- trichloroethylene, 1,1,2-dichloroethane, 1,1,1- trichloroethane and tetrachloroethylene.
12. The process of claim 1, wherein said organic solvent is 1,1,2-trichloroethane.
13. The process of claim 3, wherein said aqueous solution is an aqueous sodium bicarbonate solution.
14. The process of claim 3, wherein said aqueous solution is an aqueous sodium chloride solution.
15. The process of claim 3, wherein said aqueous solution is an aqueous sodium bicarbonate followed by a sodium chloride solution.
16. The process of claim 1, wherein said 5-amino-N,N'- bis(2,3-diacetoxypropyl)-2,4,6-triiodoisophthalamide has solvent impurities reduced or removed therefrom by distilling off said solvent impurities.
17. A process for the production of 5-acetoxyacetamido- N,N'-bis(2,3-diacetoxypropyl)-2 ,4,6- triiodoisophthalamide from 5-amino-N,N'-bis(2,3- diacetoxypropyl)-2,4,6-triiodoisophthalamide, comprising the steps of:
a. reacting N,N-dimethylacetamide, approximately 7- 36% excess of acetoxyacetamido, 5-amino-N,N'- bis (2 , 3-diacetoxypropyl) -2 , 4 , 6- triiodoisophthalamide, and an organic solvent under reaction forming conditions to form a reaction mixture; and
b. recovering 5-acetoxyacetamido-N,N'-bis-(2,3- diacetoxypropyl)-2,4,6-triiodoisophthalamide.
18. The process of claim 17 wherein said reaction mixture is diluted with an organic solvent prior to recovering 5-acetoxyacetamido-N,N'-bis-(2,3-diacetoxypropyl)- 2,4,6-triiodoisophthalamide.
19. The process of claim 17 wherein said reaction mixture is diluted with an organic solvent and extracted with an aqueous solution prior to recovering 5- acetoxyacetamido-N,N'-bis-(2,3-diacetoxypropyl)-2,4,6- triiodoisophthalamide.
20. The process of claim 17 wherein said reaction mixture is formed at a temperature within the range of 40° to 66° C.
21. The process of claim 17 wherein said reaction mixture is formed at a temperature of 50° C.
22. The process of claim 17 wherein said excess of acetoxyacetylchloride is 12%.
23. The process of claim 17 wherein a highly concentrated solution of said 5-amino-N,N'-bis-(2,3- diacetoxypropyl)-2,4,6-triiodoisophthalamide and said organic solvent is used to form said reaction mixture.
24. The process of claim 17 wherein one to three grams of said 5-amino-N,N'-bis(2,3-diacetoxypropyl)-2,4,6- triiodoisophthalamide plus up to five milliliters of said organic solvent are stirred to form a highly concentrated solution used to form said reaction mixture.
25. The process of claim 17, wherein 1.72 grams of said 5- amino-N,N'-bis(2,3-diacetoxypropyl)-2,4,6- triiodoisophthalamide plus one milliliter of
said organic solvent are stirred to form a highly concentrated solution used to form said reaction mixture.
26. The process of claim 17, wherein said organic solvent may be the same or different selected from a group consisting of carbontetrachloride, dichloromethane, chloroform, toluene, 1,2-dichloroethane, 1,1,2- trichloroethylene, 1,1,2-dichloroethane, 1,1,1- trichloroethane and tetrachloroethylene.
27. The process of claim 17, wherein said organic solvent is 1,1,2-trichloroethane.
28. The process of claim 19, wherein said aqueous solution is an aqueous sodium bicarbonate solution.
29. The process of claim 19, wherein said aqueous solution is an aqueous sodium chloride solution.
30. The process of claim 19, wherein said aqueous solution is an aqueous sodium bicarbonate followed by a sodium chloride solution.
31. The process of claim 17, wherein said 5-amino-N,N'- bis(2,3-diacetoxypropyl)-2,4,6-triiodoisophthalamide has solvent impurities reduced or removed therefrom by distilling off said solvent impurities.
32. A process for the production of a pentaacetate derivative of 5-acetoxyacetamido-N,N'-bis(2,3- diacetoxypropyl)-2,4,6-triiodoisophthalamide from 5- amino-N,N'-bis(2,3-diacetoxypropyl)-2,4,6- triiodoisophthalamide, comprising the steps of :
a . reacting N, N-dimethylacetamide, a reduced excess of acetoxyacetylchloride, 5-amino-N, N' -bis (2 , 3- diacetoxypropyl) -2 , 4 , 6-triiodoisophthalamide and an organic solvent under reaction forming conditions to form a reaction mixture ; and b. recovering 5-acetoxyacetamido-N,N'-bis-[2,3- di(acetoxypropyl)]-2,4,6-triiodoisophthalamide.
33. The process of claim 32 wherein said reaction mixture is diluted with an organic solvent prior to recovering 5-acetoxyacetamido-N,N'-bis-(2,3-diacetoxypropyl)- 2,4,6-triiodoisophthalamide.
34. The process of claim 32 wherein said reaction mixture is diluted with an organic solvent and extracted with an aqueous solvent prior to recovering 5- acetoxyacetamido-N,N'-bis-(2,3-diacetoxypropyl)-2,4,6- triiodoisophthalamide.
35. The process of claim 32 wherein said reaction mixture is formed at a temperature within the range of 40°C to 60° C.
36. The process of claim 32 wherein said reaction mixture is formed at 50° C.
37. The process of claim 32 wherein said excess of acetoxyacetylchloride is approximately 7 to 36%.
38. The process of claim 32 wherein said excess of acetoxyacetylchloride is 12%.
39. The process of claim 23 wherein a highly concentrated solution of said 5-amino-N,N'-bis-(2,3- diacetoxypropyl)-2,4,6-triiodoisophthalamide and said organic solvent is used to form said reaction mixture.
40. The process of claim 32 wherein one to three grams of said 5-amino-N,N'-bis(2,3-dihydroxypropyl)-2,4,6- triiodoisophthalamide plus up to five milliliters of said organic solvent are stirred to form a highly concentrated solution used to form said reaction mixture.
41. The process of claim 32, wherein 1.72 grams of said 5- amino-N,N'-bis(2,3-dihydroxypropyl)-2,4,6- triiodoisophthalamide plus one milliliter of said organic solvent are stirred to form a highly concentrated solution used to form said reaction mixture.
42. The process of claim 32, wherein said organic solvent may be the same or different selected from a group consisting of carbontetrachloride, dich1oromethane, chloroform, toluene, 1,2-dichloroethane, 1,1,2- trichloroethylene, 1,1,2-dichloroethane, 1,1,1- trichloroethane and tetrachloroethylene.
43. The process of claim 32, wherein said organic solvent is 1,1,2-trichloroethane.
44. The process of claim 34, wherein said aqueous solution is an aqueous sodium chloride solution.
45. The process of claim 34, wherein said aqueous solution is an aqueous sodium bicarbonate solution.
46. The process of claim 34, wherein said aqueous solution is an aqueous sodium bicarbonate solution followed by a sodium chloride solution.
PCT/US1993/002033 1992-02-28 1993-02-23 Synthesis of ioversol using a minimal excess of acetoxyacetylchloride WO1993016981A1 (en)

Priority Applications (2)

Application Number Priority Date Filing Date Title
JP5515135A JPH07504419A (en) 1992-02-28 1993-02-23 Synthesis of Ioversol using a minimal excess of acetoxyacetyl chloride
EP93907271A EP0628024A4 (en) 1992-02-28 1993-02-23 Synthesis of ioversol using a minimal excess of acetoxyacetylchloride.

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US84404292A 1992-02-28 1992-02-28
US07/844,042 1992-02-28

Publications (1)

Publication Number Publication Date
WO1993016981A1 true WO1993016981A1 (en) 1993-09-02

Family

ID=25291646

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US1993/002033 WO1993016981A1 (en) 1992-02-28 1993-02-23 Synthesis of ioversol using a minimal excess of acetoxyacetylchloride

Country Status (5)

Country Link
EP (1) EP0628024A4 (en)
JP (1) JPH07504419A (en)
AU (1) AU3793293A (en)
CA (1) CA2130829A1 (en)
WO (1) WO1993016981A1 (en)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1998024757A1 (en) * 1996-12-04 1998-06-11 Dibra S.P.A. A process for the preparation of 5-amino-2,4,6-triiodo-1,3-benzenedicarboxylic acid derivatives
WO2023104063A1 (en) * 2022-01-17 2023-06-15 安庆朗坤药业有限公司 Preparation method for ioversol hydrolysate

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4256729A (en) * 1979-03-23 1981-03-17 Mallinckrodt, Inc. N,N'-Bis-(2,3-dihydroxypropyl)-2,4,6-triiodo-5-(2-keto-L-gulonamido)isophthalamide and radiological compositions containing same
US5043152A (en) * 1988-06-02 1991-08-27 Guerbet S.A. Novel iodinated non-ionic triiodobenzene compounds and contrast media containing them

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4256729A (en) * 1979-03-23 1981-03-17 Mallinckrodt, Inc. N,N'-Bis-(2,3-dihydroxypropyl)-2,4,6-triiodo-5-(2-keto-L-gulonamido)isophthalamide and radiological compositions containing same
US5043152A (en) * 1988-06-02 1991-08-27 Guerbet S.A. Novel iodinated non-ionic triiodobenzene compounds and contrast media containing them

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
See also references of EP0628024A4 *

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1998024757A1 (en) * 1996-12-04 1998-06-11 Dibra S.P.A. A process for the preparation of 5-amino-2,4,6-triiodo-1,3-benzenedicarboxylic acid derivatives
WO2023104063A1 (en) * 2022-01-17 2023-06-15 安庆朗坤药业有限公司 Preparation method for ioversol hydrolysate

Also Published As

Publication number Publication date
EP0628024A1 (en) 1994-12-14
EP0628024A4 (en) 1995-03-22
CA2130829A1 (en) 1993-09-02
JPH07504419A (en) 1995-05-18
AU3793293A (en) 1993-09-13

Similar Documents

Publication Publication Date Title
EP1150943B1 (en) Preparation of iodixanol
EP1960349A1 (en) Purification of iodixanol
EP0839056B1 (en) Process for producing ioversol
US5371278A (en) Synthesis of ioversol using a minimal excess of acetoxyacetylchloride
US6596904B1 (en) Process for producing ioversol
EP0598751B1 (en) Synthesis of ioversol using chloroacetyl chloride
JP4039700B2 (en) Production of triiodobenzene compounds
WO1993016981A1 (en) Synthesis of ioversol using a minimal excess of acetoxyacetylchloride
JP2007521262A (en) Method for producing iohexol
EP0640067B1 (en) Improved synthesis of ioversol
JPH107636A (en) Production of intermediate useful for synthesizing iodide contrast medium
EP0580783A1 (en) Use of azeotropic distillation in process to dry 5-amino-n,n'bis(2,3-dihydroxypropyl)-2,4,6-triiodoisophthalamide
CN116854610A (en) Process for the preparation of impurities K and H of iopamidol and intermediates thereof
CN114213273A (en) Synthesis method of iomeprol
DK200100402A (en) Process for removing desmethyl citalopram from a citalopram product

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A1

Designated state(s): AU CA JP

AL Designated countries for regional patents

Kind code of ref document: A1

Designated state(s): AT BE CH DE DK ES FR GB GR IE IT LU MC NL PT SE

DFPE Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101)
WWE Wipo information: entry into national phase

Ref document number: 2130829

Country of ref document: CA

WWE Wipo information: entry into national phase

Ref document number: 1993907271

Country of ref document: EP

WWP Wipo information: published in national office

Ref document number: 1993907271

Country of ref document: EP

WWW Wipo information: withdrawn in national office

Ref document number: 1993907271

Country of ref document: EP